Agalsidase Beta Long-Term Treatment Outcome for Fabry Disease Patients With IVS4 Mutation in Taiwan
Clinical trial NCT06052800 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06052800
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-13
- Primary completion
- 2026-09-10
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.